KDM1A and breast cancer: LSD1 has been implicated in the maintenance of a variety of cancer types, including neuroblastoma [12], breast cancer [13], prostate cancer [14], colon cancer [15], etc., and elevated LSD1 expression correlates well with tumor progression and unfavorable clinical outcomes [15, 16].